Covered recipient · General Payments record
ALANA LEVINE
General Payments · PY2019–2025
$1,844.16
- Reported across 90 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.31 | 11 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $91.18 | 3 |
| Janssen Biotech, Inc. | $62.92 | 2 |
| ABBVIE INC. | $61.93 | 3 |
| Amgen Inc. | $25.59 | 1 |
| Lilly USA, LLC | $25.55 | 1 |
| GlaxoSmithKline, LLC. | $23.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.48 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202294586 | CMS |
| ABBVIE INC. | $18.88 | 05/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202294588 | CMS |
| ABBVIE INC. | $22.57 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202294590 | CMS |
| Amgen Inc. | $25.59 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228567342 | CMS |
| GlaxoSmithKline, LLC. | $23.14 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191244707 | CMS |
| Janssen Biotech, Inc. | $33.20 | 07/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175400228 | CMS |
| Janssen Biotech, Inc. | $29.72 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175420428 | CMS |
| Lilly USA, LLC | $25.55 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186492693 | CMS |
| Novartis Pharmaceuticals Corporation | $34.05 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200647089 | CMS |
| Novartis Pharmaceuticals Corporation | $22.55 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200647091 | CMS |
| Novartis Pharmaceuticals Corporation | $34.58 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200647097 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.